Crinetics Pharmaceuticals
Presença
Crinetics Pharmaceuticals é uma das ...
Crinetics Pharmaceuticals é uma empresa listada sob o símbolo CRNX (US).
Executivos
Veja o organograma con seus 21 executivos principais
Biografias mais buscadas da Crinetics Pharmaceuticals
- Scott Struthers, Chief Executive Officer and Director
- Camille Bedrosian, Director
- Wendell Wierenga, Chairman of the Board
Criar um alerta
para seguir os movimentos de executivos da Crinetics Pharmaceuticals.
Farmacêutica
Crinetics Pharmaceuticals possui 1.861 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals to Participate in September Investor Conferences - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Receives Orphan Drug Designation for Paltusotine for the Treatment of Acromegaly - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Crinetics Pharmaceuticals
- View more press releases Close
Redes sociais sobre Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Crinetics Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Scott Struthers 
Ligue para a Crinetics Pharmaceuticals em +1 858...
